Ligands for the innate immune sensors such as toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I), nucleotide-binding oligomerization domain (NOD) have been reported to potentially enhance anti-tumor immunity. Here, RIGI is linked to neoplasm.